As of 2024-12-14, the Intrinsic Value of PMV Pharmaceuticals Inc (PMVP) is
-4.97 USD. This PMVP valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.58 USD, the upside of PMV Pharmaceuticals Inc is
-414.71%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-4.97 USD
Intrinsic Value
PMVP Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-4.97 - -4.97 |
-4.97 |
-414.71% |
| P/E |
(20.84) - (19.33) |
(22.55) |
-1527.2% |
| DDM - Stable |
(4.44) - (9.69) |
(7.07) |
-547.3% |
| DDM - Multi |
(5.01) - (8.70) |
(6.38) |
-503.6% |
PMVP Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
81.76 |
| Beta |
1.26 |
| Outstanding shares (mil) |
51.75 |
| Enterprise Value (mil) |
32.96 |
| Market risk premium |
4.60% |
| Cost of Equity |
16.46% |
| Cost of Debt |
5.00% |
| WACC |
10.73% |